-
Mashup Score: 13Survival outcomes of pulmonary metastasis‐directed local therapy in adenoid cystic carcinoma - 10 hour(s) ago
The largest study of survival outcomes of pulmonary metastasis–directed local therapy (PM-LT) in adenoid cystic carcinoma (ACC) and the only study to compare survival outcomes between patients who di…
Categories: General Medicine NewsTweet
-
Mashup Score: 2Cancer statistics for African American and Black people, 2025 - 10 hour(s) ago
African American and other Black individuals (referred to as Black people in this article) have a disproportionate cancer burden, including the lowest survival of any racial or ethnic group for most …
Categories: General Medicine NewsTweet-
During #ColorectalCancerAwarenessMonth, read @AmericanCancer’s latest stats showing #ColorectalCancer as the 3rd most common cancer & 3rd leading cause of cancer death among Black Americans. Addressing SES-related disparities will improve outcomes: https://t.co/WRbSqOKmSE https://t.co/uFnmPn39LH
-
-
Mashup Score: 7The American Cancer Society launches the VOICES of Black Women, a longitudinal population cohort study - 11 hour(s) ago
The American Cancer Society has launched a new population cohort study, VOICES of Black Women, to examine the impact of established health determinants (e.g., smoking, exercise) and novel areas of em…
Categories: General Medicine NewsTweet-
.@AmericanCancer launched VOICES of Black Women in 2024 to address cancer disparities & improve outcomes among Black women. This editorial explores the study's rationale & early insights: https://t.co/iqjPObHobs @Dr_LEMcCullough @DrRobWinn @LRTeras @AlpaVPatel @OncoAlert https://t.co/lakxGd94hT
-
-
Mashup Score: 0Cancer treatment and survivorship statistics, 2025 - 1 day(s) ago
The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early de…
Categories: General Medicine NewsTweet-
#Cancer treatment and #survivorship statistics, 2025 https://t.co/U0VDuuU5nB
-
-
Mashup Score: 15
The combination of platinum/etoposide and nivolumab improves both progression-free survival and overall survival for patients with ES-SCLC. No new safety signals were observed.
Categories: General Medicine NewsTweet-
Just published: The combination of etoposide and nivolumab improves both progression-free survival and overall survival for patients with extensive-stage small cell lung cancer. https://t.co/yKvFuBtXYO @OncoAlert @LealTiciana @RamalingamMD @SclcSMASHERS #LCSM #SCLC https://t.co/rPaNC4tbhU
-
-
Mashup Score: 62Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types - 2 day(s) ago
Reirradiation (reRT), defined as administering a course of radiation therapy to a specific area previously irradiated, is an evolving treatment strategy for locoregionally recurrent cancer that offer…
Categories: General Medicine NewsTweet-
RT @medoncodoc: Ultimate review on Reirradiation. All that you need to know in one place. Must read!! https://t.co/CJJhTCmYtI @OncoAlert…
-
-
Mashup Score: 14
This phase 1 study shows the feasibility and safety of combining dose-escalated radiation (up to 60 Gy) with high-dose nab-paclitaxel for locally advanced pancreatic cancer, achieving low dose-limiti…
Categories: General Medicine NewsTweet-
This study demonstrates the feasibility and safety of combining dose-escalated radiation with high-dose nab-paclitaxel in locally advanced pancreatic cancer. https://t.co/xY0Vs57KDE @OncoAlert @PennMedicine #RadOnc https://t.co/2EEe5UytSB
-
-
Mashup Score: 6
Over a 20-year period, 4.5% (140 of 3125) of Canadian children who died of cancer were enrolled in early phase studies in their last 90 days of life. Enrollment was associated with a brain tumor diag…
Categories: General Medicine NewsTweet-
A small proportion of Canadian children and adolescents participate in early phase trials toward end of life. Future research should seek to address barriers to ensure equitable access for diverse populations. https://t.co/nHE0GbEViL @oncoalert @SickKidsGlobal @sung_lillian https://t.co/LYxOt7UDbU
-
-
Mashup Score: 23Current landscape and emerging opportunities for using telecytology for rapid on‐site assessment in cytopathology - 2 day(s) ago
Telecytology for rapid on-site assessment is becoming a necessity in cytology practices. The landscape of telecytology is evolving with the availability of different options, each of which has advant…
Categories: General Medicine NewsTweet-
#Telecytology for rapid on-site assessment is becoming a necessity in cytology practices. The landscape of telecytology is evolving with the availability of different options, each of which has advantages and limitations. https://t.co/rE8v0r2AcR @MDAndersonNews #CytoPath https://t.co/HcLSxzHbkl
-
-
Mashup Score: 6Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies - 2 day(s) ago
This review examines HER2 alterations as emerging therapeutic targets in non–small cell lung cancer, highlighting trastuzumab deruxtecan as the first Food and Drug Administration-approved HER2-direct…
Categories: General Medicine NewsTweet-
The review article linked below, appearing in the latest @JournalCancer supplement issue, examines HER2 alterations as emerging therapeutic targets in non-small cell lung cancer. 🔗https://t.co/YbI2W83J3p @ACS_Research https://t.co/6S9HwczDAP
-
This is the largest study of survival outcomes of pulmonary metastasis–directed local therapy (PM-LT) in metastatic adenoid cystic carcinoma (ACC). Findings suggest PM-LT does not increase overall survival in unselected ACC. https://t.co/FWK368z4FX @OncoAlert https://t.co/YbEP17LZoL